QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, January 5, 2005, 25(1):29-41; doi:10.1523/JNEUROSCI.3754-04.2005

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (52) Citing Articles via Google Scholar Google Scholar Articles by Samuvel, D. J. Articles by Ramamoorthy, S. Search for Related Content PubMed PubMed Citation Articles by Samuvel, D. J. Articles by Ramamoorthy, S.

 Previous Article  |  Next Article 

Cellular/Molecular
A Role for p38 Mitogen-Activated Protein Kinase in the Regulation of the Serotonin Transporter: Evidence for Distinct Cellular Mechanisms Involved in Transporter Surface Expression

Devadoss J. Samuvel,¹ Lankupalle D. Jayanthi,¹ Narayan R. Bhat,² and Sammanda Ramamoorthy¹

Departments of ¹Physiology and Neuroscience and ²Neurology, Medical University of South Carolina, Charleston, South Carolina 29425

The serotonin transporter (SERT) is regulated by various signaling mechanisms that may operate to maintain appropriate levels of synaptic serotonin (5-HT). We demonstrate that one of the mitogen-activated protein kinases (MAPKs), p38 MAPK, regulates SERT. Treatment of rat midbrain synaptosomes with p38 MAPK-specific inhibitors, PD169316 [4-(4-fluorophenyl)-2-(4-nitrophenyl)-5-(4-pyridyl)-1H-imidazole] or SB203580 [4-(4-fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole], reduced 5-HT uptake. An additive SERT inhibition by PD169316 and -phorbol 12-myristate 13-acetate (-PMA) indicated the involvement of a protein kinase C (PKC)-independent MAPK pathway. Kinetic studies indicated a significant decrease in the transport capacity (V_max) after PD169316 treatment of synaptosomes. Biotinylation studies showed reduced SERT proteins in the plasma membrane of synaptosomes after p38 MAPK inhibition and PKC activation. Phosphorylation studies using synaptosomes revealed decreased SERT phosphorylation by PD169316 but increased phosphorylation by -PMA. D-Amphetamine enhanced SERT basal phosphorylation and PD169316 blocked this effect. SERT interaction with protein phosphatase 2A catalytic subunit and syntaxin 1A decreased after PD169316 or -PMA treatment of synaptosomes. In synaptosomes, PKC activation but not p38 MAPK inhibition resulted in SERT redistribution from cholesterolrich lipid raft fractions to nonlipid raft fractions. The presence of phospho-p38 MAPK in synaptosomes and human embryonic kidney 293 (HEK-293) cells suggested the presence of constitutively active p38 MAPK in these preparations. Cotransfection of HEK-293 cells with SERT and a constitutively active form of MAP kinase kinase 3b(E) [MKK3b(E)] increased 5-HT transport, and RNA interference targeted to p38 MAPK inhibited 5-HT uptake, confirming the involvement of active p38 MAPK in SERT expression. Although PD169316 inhibited SERT insertion to the plasma membrane, -PMA increased SERT internalization in HEK-293 cells. Together, these results indicate a distinct role of p38 MAPK in SERT regulation.

Key words: neurotransmitter; phosphorylation; presynaptic; uptake; trafficking; lipid rafts

---

Received May 26, 2004; revised November 4, 2004; accepted November 12, 2004.

This article has been cited by other articles:

				C. Mendoza, N. Matheus, R. Iceta, J. E. Mesonero, and A. I. Alcalde Lipopolysaccharide induces alteration of serotonin transporter in human intestinal epithelial cells Innate Immunity, August 1, 2009; 15(4): 243 - 250. [Abstract] [PDF]

				U. Hasler Controlled aquaporin-2 expression in the hypertonic environment Am J Physiol Cell Physiol, April 1, 2009; 296(4): C641 - C653. [Abstract] [Full Text] [PDF]

				H. C Prasad, J. A Steiner, J. S Sutcliffe, and R. D Blakely Enhanced activity of human serotonin transporter variants associated with autism Phil Trans R Soc B, January 27, 2009; 364(1514): 163 - 173. [Abstract] [Full Text] [PDF]

				K.-H. Jung, J.-Y. Paik, B.-H. Ko, and K.-H. Lee Mitogen-Activated Protein Kinase Signaling Enhances Sodium Iodide Symporter Function and Efficacy of Radioiodide Therapy in Nonthyroidal Cancer Cells J. Nucl. Med., December 1, 2008; 49(12): 1966 - 1972. [Abstract] [Full Text] [PDF]

				U. Hasler, P. Nunes, R. Bouley, H. A. J. Lu, T. Matsuzaki, and D. Brown Acute Hypertonicity Alters Aquaporin-2 Trafficking and Induces a MAPK-dependent Accumulation at the Plasma Membrane of Renal Epithelial Cells J. Biol. Chem., September 26, 2008; 283(39): 26643 - 26661. [Abstract] [Full Text] [PDF]

				C-W. Tsao, Y-S. Lin, J-T. Cheng, C-F. Lin, H-T. Wu, S-R. Wu, and W-H. Tsai Interferon-{alpha}-induced serotonin uptake in Jurkat T cells via mitogen-activated protein kinase and transcriptional regulation of the serotonin transporter J Psychopharmacol, September 1, 2008; 22(7): 753 - 760. [Abstract] [PDF]

				O. V. Mortensen, M. B. Larsen, B. M. Prasad, and S. G. Amara Genetic Complementation Screen Identifies a Mitogen-activated Protein Kinase Phosphatase, MKP3, as a Regulator of Dopamine Transporter Trafficking Mol. Biol. Cell, July 1, 2008; 19(7): 2818 - 2829. [Abstract] [Full Text] [PDF]

				Y. Dempsie, I. Morecroft, D. J. Welsh, N. A. MacRitchie, N. Herold, L. Loughlin, M. Nilsen, A. J. Peacock, A. Harmar, M. Bader, et al. Converging Evidence in Support of the Serotonin Hypothesis of Dexfenfluramine-Induced Pulmonary Hypertension With Novel Transgenic Mice Circulation, June 3, 2008; 117(22): 2928 - 2937. [Abstract] [Full Text] [PDF]

				T. Lau, S. Horschitz, S. Berger, D. Bartsch, and P. Schloss Antidepressant-induced internalization of the serotonin transporter in serotonergic neurons FASEB J, June 1, 2008; 22(6): 1702 - 1714. [Abstract] [Full Text] [PDF]

				D. J. Samuvel, L. D. Jayanthi, S. Manohar, K. Kaliyaperumal, R. E. See, and S. Ramamoorthy Dysregulation of Dopamine Transporter Trafficking and Function after Abstinence from Cocaine Self-Administration in Rats: Evidence for Differential Regulation in Caudate Putamen and Nucleus Accumbens J. Pharmacol. Exp. Ther., April 1, 2008; 325(1): 293 - 301. [Abstract] [Full Text] [PDF]

				A. Zapata, B. Kivell, Y. Han, J. A. Javitch, E. A. Bolan, D. Kuraguntla, V. Jaligam, M. Oz, L. D. Jayanthi, D. J. Samuvel, et al. Regulation of Dopamine Transporter Function and Cell Surface Expression by D3 Dopamine Receptors J. Biol. Chem., December 7, 2007; 282(49): 35842 - 35854. [Abstract] [Full Text] [PDF]

				M. R. Bruchas, B. B. Land, M. Aita, M. Xu, S. K. Barot, S. Li, and C. Chavkin Stress-Induced p38 Mitogen-Activated Protein Kinase Activation Mediates {kappa}-Opioid-Dependent Dysphoria J. Neurosci., October 24, 2007; 27(43): 11614 - 11623. [Abstract] [Full Text] [PDF]

				M. I. Gonzalez, E. Krizman-Genda, and M. B. Robinson Caveolin-1 Regulates the Delivery and Endocytosis of the Glutamate Transporter, Excitatory Amino Acid Carrier 1 J. Biol. Chem., October 12, 2007; 282(41): 29855 - 29865. [Abstract] [Full Text] [PDF]

				Y.-W. Zhang, J. Gesmonde, S. Ramamoorthy, and G. Rudnick Serotonin Transporter Phosphorylation by cGMP-Dependent Protein Kinase Is Altered by a Mutation Associated with Obsessive Compulsive Disorder J. Neurosci., October 3, 2007; 27(40): 10878 - 10886. [Abstract] [Full Text] [PDF]

				H. A. Boger, L. D. Middaugh, K. S. Patrick, S. Ramamoorthy, E. D. Denehy, H. Zhu, A. M. Pacchioni, A.-C. Granholm, and J. F. McGinty Long-Term Consequences of Methamphetamine Exposure in Young Adults Are Exacerbated in Glial Cell Line-Derived Neurotrophic Factor Heterozygous Mice J. Neurosci., August 15, 2007; 27(33): 8816 - 8825. [Abstract] [Full Text] [PDF]

				C.-B. Zhu, J. A. Steiner, J. L. Munn, L. C. Daws, W. A. Hewlett, and R. D. Blakely Rapid Stimulation of Presynaptic Serotonin Transport by A3 Adenosine Receptors J. Pharmacol. Exp. Ther., July 1, 2007; 322(1): 332 - 340. [Abstract] [Full Text] [PDF]

				B. Chanrion, C. Mannoury la Cour, F. Bertaso, M. Lerner-Natoli, M. Freissmuth, M. J. Millan, J. Bockaert, and P. Marin From the Cover: Physical interaction between the serotonin transporter and neuronal nitric oxide synthase underlies reciprocal modulation of their activity PNAS, May 8, 2007; 104(19): 8119 - 8124. [Abstract] [Full Text] [PDF]

				S. Ramamoorthy, D. J. Samuvel, E. R. Buck, G. Rudnick, and L. D. Jayanthi Phosphorylation of Threonine Residue 276 Is Required for Acute Regulation of Serotonin Transporter by Cyclic GMP J. Biol. Chem., April 20, 2007; 282(16): 11639 - 11647. [Abstract] [Full Text] [PDF]

				A. M. D. Carneiro and R. D. Blakely Serotonin-, Protein Kinase C-, and Hic-5-associated Redistribution of the Platelet Serotonin Transporter J. Biol. Chem., August 25, 2006; 281(34): 24769 - 24780. [Abstract] [Full Text] [PDF]

				L. D. Jayanthi, B. Annamalai, D. J. Samuvel, U. Gether, and S. Ramamoorthy Phosphorylation of the Norepinephrine Transporter at Threonine 258 and Serine 259 Is Linked to Protein Kinase C-mediated Transporter Internalization J. Biol. Chem., August 18, 2006; 281(33): 23326 - 23340. [Abstract] [Full Text] [PDF]

				N. P. Poolos, J. B. Bullis, and M. K. Roth Modulation of h-channels in hippocampal pyramidal neurons by p38 mitogen-activated protein kinase. J. Neurosci., July 26, 2006; 26(30): 7995 - 8003. [Abstract] [Full Text] [PDF]

				M. A. Cervinski, J. D. Foster, and R. A. Vaughan Psychoactive Substrates Stimulate Dopamine Transporter Phosphorylation and Down-regulation by Cocaine-sensitive and Protein Kinase C-dependent Mechanisms J. Biol. Chem., December 9, 2005; 280(49): 40442 - 40449. [Abstract] [Full Text] [PDF]

				X. Wang, M. H. Baumann, H. Xu, M. Morales, and R. B. Rothman ({+/-})-3,4-Methylenedioxymethamphetamine Administration to Rats Does Not Decrease Levels of the Serotonin Transporter Protein or Alter Its Distribution between Endosomes and the Plasma Membrane J. Pharmacol. Exp. Ther., September 1, 2005; 314(3): 1002 - 1012. [Abstract] [Full Text] [PDF]

				R. D. Blakely, L. J. DeFelice, and A. Galli Biogenic Amine Neurotransmitter Transporters: Just When You Thought You Knew Them Physiology, August 1, 2005; 20(4): 225 - 231. [Abstract] [Full Text] [PDF]

				L. D. Jayanthi, D. J. Samuvel, R. D. Blakely, and S. Ramamoorthy Evidence for Biphasic Effects of Protein Kinase C on Serotonin Transporter Function, Endocytosis, and Phosphorylation Mol. Pharmacol., June 1, 2005; 67(6): 2077 - 2087. [Abstract] [Full Text] [PDF]

				C.-B. Zhu, A. M. Carneiro, W. R. Dostmann, W. A. Hewlett, and R. D. Blakely p38 MAPK Activation Elevates Serotonin Transport Activity via a Trafficking-independent, Protein Phosphatase 2A-dependent Process J. Biol. Chem., April 22, 2005; 280(16): 15649 - 15658. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help